PP
AMAG

Prospector Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Prospector Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,300
Closed -$1.38M – 164
2015
Q1 		$1.38M Sell
25,300
-14,300
-36% -$682K 0.1% 132
2014
Q4 		$1.69M Hold
39,600
– – 0.13% 128
2014
Q3 		$1.26M Hold
39,600
– – 0.07% 155
2014
Q2 		$821K Hold
39,600
– – 0.04% 174
2014
Q1 		$766K Buy
+39,600
New +$841K 0.04% 174

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prospector Partners's AMAG Position: Q2 2015 in Review

Prospector Partners sold out of AMAG Pharmaceuticals (AMAG) in Q2 2015, closing a stake of 25,300 shares — an estimated $1.38M sold.

Prospector Partners first reported a position in AMAG in Q1 2014 and held it in 5 quarters. The position peaked at $1.69M in Q4 2014. 208 funds tracked by Wall St. Rank hold AMAG as of Q2 2015.

  • Prospector Partners reported no remaining AMAG Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Prospector Partners sold 25,300 AMAG Pharmaceuticals shares in Q2 2015, an estimated $1.38M.
  • Prospector Partners first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Prospector Partners's AMAG Pharmaceuticals position peaked at $1.69M in Q4 2014.
  • 208 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2015.

Based on Prospector Partners's 13F filing for Q2 2015, filed 14 Aug 2015.